|
|
Post by mdcenter61 on Dec 18, 2014 13:51:33 GMT -5
|
|
|
|
Post by liane on Dec 18, 2014 17:11:31 GMT -5
I voted for him - he he he!  |
|
|
|
Post by mnholdem on Dec 18, 2014 18:08:42 GMT -5
Wasn't he a hedge fund manager when he unethically obtained all those FDA email addresses and sent an appeal on Christmas Eve to FDA brass to issue the CRL to MannKind insisting they prove the Gen2 inhaler (Dreamboat) deliver TI accurately?
Was he a CEO back then? It was my understanding that his emails to the FDA indicated he had over a million ($ or shares) shorted. I'm still angry about the FDA issuing that CRL shortly after, since basically any high-quality flowmeter could have proven the device. In fact, I think MannKind sent independent analysis results to that effect.
The CRL set Afrezza back two years and cost another $500 million.
|
|
|
|
Post by brentie on Dec 18, 2014 19:04:09 GMT -5
Wasn't he a hedge fund manager when he unethically obtained all those FDA email addresses and sent an appeal on Christmas Eve to FDA brass to issue the CRL to MannKind insisting they prove the Gen2 inhaler (Dreamboat) deliver TI accurately? Was he a CEO back then? It was my understanding that his emails to the FDA indicated he had over a million ($ or shares) shorted. I'm still angry about the FDA issuing that CRL shortly after, since basically any high-quality flowmeter could have proven the device. In fact, I think MannKind sent independent analysis results to that effect. The CRL set Afrezza back two years and cost another $500 million. MannKind’s Afrezza Was To Be Approved; What Happened Next? www.gurufocus.com/news/159641/mannkinds-afrezza-was-to-be-approved-what-happened-next- |
|
|
|
Post by alcc on Dec 18, 2014 19:21:54 GMT -5
Wise guys turning on each other. Coal calling the kettle black...
|
|
|
|
Post by BlueCat on Dec 19, 2014 12:09:02 GMT -5
I've been spectating this for the past half a year, and have observed a consistency to the arguments by the bashers (or perma-bears.)
You can rank the basher by the relevance - moving from the absurd to the more sophisticated. And to my surprise, rather than progress toward launch requiring increasingly sophisticated methods, the really absurd stuff still appears to be employed to catch traders who have done no DD at all.
Level 0: It is a Scam. Its not FDA approved and they haven't secured a partner. It is going to $1 with CEO shorting his own company and sinking stock price waiting for notes to convert. Or the company is about to run out of money with current burn rate and go bankrupt and is hiding this from the public. Look to other biotech scams.
Level 1: No market - Patients won't want or need it, and its really, really niche. Anyway, patients really like needles, liver damaging pills or prefer toting around an expensive battery-powered pump. (And if MNKD knew this, see Level 0)
Level 2: No science or use case - Doctors won't want to or dare prescribe it. Isn't there another CRL anyway?
Level 3: Not sold - SNY got rights just to shelf it or will not execute due to company problems, and will change mind last minute.
Level 4: No coverage - SNY will sell, but fail because insurers won't cover it. Out of market.
Level 5: Not preferred - It won't be covered enough (Tier 4 or 3 only) or competitively priced.
Level 6: Not profitable - Will sell, but bad deal for MNKD and poor margin structure. Milestones have to be paid back.
Level 7: No capacity - Will have demand and will sell, but cannot ramp production enough to ever be profitable, or soon enough to matter.
Level 8: Not fast enough - Controlled launch and slow ramp possibly SNY waiting for higher priority efforts like Toujeo will result in MNKD starving for profit until finally, a better solution is brought to market.
Level 9: Not good enough management - Business and science is all there, but Al Mann isn't paying attention with focus on EYES, or isn't interested or invested in company, investor or even financial success and is depending on other people to poorly execute MNKD. Or he'll pass away and company will fall to chaos. You are really taking your chances.
Level 10: Just not enough. They aren't communicating either because of Level 9, or they are up to something. But silence can't be good. We don't know what the problem is - but clearly, just look at the short interest - they must know something! GS knows their business! In any case, its dead money for a long time to come. So sure - if you are a 'true long' - you can hold your money for another few years and make a dollar or two per share. But there are much better trades or investments out there. How about just taking the pain now, write off the loss and look at buying XYZ company instead? Just sayin' - follow the "smart" money.
The real art is that starting about Level 5 up - you have to do some DD to get solid answers or theories and push through the considerable FUD. And bashers can sound like honest investors - and the other way around. Especially on a bad day. And that includes me.
But herein lies the dream - it requires a truly contrarian investment to make a serious return. And, the level of investment on the bash wouldn't be as high as it is to push out all other investors - if there wasn't serious coin to make here.
GLTU All - Stay thirsty. I sure am.
|
|
|
|
Post by mnholdem on Dec 19, 2014 13:31:48 GMT -5
Great post, oh Omnipotent One!
You know the real irony is that the really good bashers inadvertently lead me to excellent information while I'm searching to determine whether their posts hold weight. So the really good basher is shooting himself in the foot a bit, but doesn't care because many readers don't research the claims made.
The most insidious bash is the one that has 90% fact and then some FUD is seeded in the message. The most popular of these Trojan horses is the one where you have to wait a long period of time for a profit, such as "I don't mind patiently waiting another 5 years to make a 60%-80% return on my investment".
Good fortune.
|
|
